<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Fidelity International Index Fund Institutional Premium Class — News on 6ix</title>
<link>https://6ix.com/company/fidelity-international-index-fund-institutional-premium-class</link>
<description>Latest news and press releases for Fidelity International Index Fund Institutional Premium Class on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/fidelity-international-index-fund-institutional-premium-class" rel="self" type="application/rss+xml" />
<item>
<title>Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting</title>
<link>https://6ix.com/company/fidelity-international-index-fund-institutional-premium-class/news/black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/fidelity-international-index-fund-institutional-premium-class/news/black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>Poster also to be presented on the Phase 2 data of silevertinib in recurrent EGFRm NSCLC patients Trial-in-progress poster to be presented on the randomized</description>
</item>
<item>
<title>Enpro Announces Date for First Quarter 2026 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/fidelity-international-index-fund-institutional-premium-class/news/enpro-announces-date-for-first-quarter-2026-earnings-release-and-conference-call-18</link>
<guid isPermaLink="true">https://6ix.com/company/fidelity-international-index-fund-institutional-premium-class/news/enpro-announces-date-for-first-quarter-2026-earnings-release-and-conference-call-18</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C.--(BUSINESS WIRE)-- Enpro Inc. (NYSE: NPO) will release financial results for the first quarter of 2026 on Tuesday, May 5, at 6:30 a.m.</description>
</item>
</channel>
</rss>